{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:19:11Z","timestamp":1761535151386,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":1916,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFC0905000","2016YFC0905001"],"award-info":[{"award-number":["2016YFC0905000","2016YFC0905001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National High Technology Research and Development Program of China","award":["2012AA02A518"],"award-info":[{"award-number":["2012AA02A518"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81522048","81573511","81273595","and 81403017"],"award-info":[{"award-number":["81522048","81573511","81273595","and 81403017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2016CX024","2015zzts117"],"award-info":[{"award-number":["2016CX024","2015zzts117"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1111\/jth.13542","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T11:06:41Z","timestamp":1476443201000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of novel variants associated with warfarin stable dosage by use of a two\u2010stage extreme phenotype strategy"],"prefix":"10.1016","volume":"15","author":[{"given":"Z.","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7167-8332","authenticated-orcid":false,"given":"X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13542_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.tpj.6500417","article-title":"Pharmacogenetics of warfarin: current status and future challenges","volume":"7","author":"Wadelius","year":"2007","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/jth.13542_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2003-44463","article-title":"Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors","volume":"3","author":"Hylek","year":"2003","journal-title":"Semin Vasc Med"},{"key":"10.1111\/jth.13542_bb0020","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa044503","article-title":"Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose","volume":"352","author":"Rieder","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13542_bb0025","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1161\/CIRCULATIONAHA.107.737312","article-title":"Randomized trial of genotype\u2010guided versus standard warfarin dosing in patients initiating oral anticoagulation","volume":"116","author":"Anderson","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/jth.13542_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.clpt.6100453","article-title":"Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes","volume":"84","author":"Wen","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jth.13542_bb0035","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1310669","article-title":"A pharmacogenetic versus a clinical algorithm for warfarin dosing","volume":"369","author":"Kimmel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13542_bb0040","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa1311386","article-title":"A randomized trial of genotype\u2010guided dosing of warfarin","volume":"369","author":"Pirmohamed","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13542_bb0045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.thromres.2015.06.032","article-title":"Comparison of the performance of the warfarin pharmacogenetics algorithms in patients with surgery of heart valve replacement and heart valvuloplasty","volume":"136","author":"Xu","year":"2015","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13542_bb0050","first-page":"930","article-title":"Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement","volume":"67","author":"Tan","year":"2012","journal-title":"Pharmazie"},{"key":"10.1111\/jth.13542_bb0055","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/CIRCULATIONAHA.108.774307","article-title":"Rheumatic heart disease in Asia","volume":"118","author":"Carapetis","year":"2008","journal-title":"Circulation"},{"key":"10.1111\/jth.13542_bb0060","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/jth.13542_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gr.129668.111","article-title":"Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition","volume":"22","author":"Ramsey","year":"2012","journal-title":"Genome Res"},{"key":"10.1111\/jth.13542_bb0070","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ng.2344","article-title":"Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis","volume":"44","author":"Emond","year":"2012","journal-title":"Nat Genet"},{"key":"10.1111\/jth.13542_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000337300","article-title":"Two\u2010stage extreme phenotype sequencing design for discovering and testing common and rare genetic variants: efficiency and power","volume":"73","author":"Kang","year":"2012","journal-title":"Hum Hered"},{"key":"10.1111\/jth.13542_bb0080","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/gepi.20628","article-title":"Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies","volume":"35","author":"Li","year":"2011","journal-title":"Genet Epidemiol"},{"key":"10.1111\/jth.13542_bb0085","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1753-6561-5-S9-S105","article-title":"Digging into the extremes. A useful approach for the analysis of rare variants with continuous traits?","volume":"5","author":"Lamina","year":"2011","journal-title":"BMC Proc"},{"key":"10.1111\/jth.13542_bb0090","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.111.038836","article-title":"Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose","volume":"39","author":"Zhang","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jth.13542_bb0095","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00228-012-1448-6","article-title":"Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage","volume":"69","author":"Wang","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jth.13542_bb0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1182\/blood-2008-01-134247","article-title":"A genome\u2010wide scan for common genetic variants with a large influence on warfarin maintenance dose","volume":"112","author":"Cooper","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.13542_bb0105","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1371\/journal.pbio.0060107","article-title":"Mapping the genetic architecture of gene expression in human liver","volume":"6","author":"Schadt","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1111\/jth.13542_bb0110","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(13)60681-9","article-title":"Genetic variants associated with warfarin dose in African\u2010American individuals: a genome\u2010wide association study","volume":"382","author":"Perera","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/jth.13542_bb0115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.thromres.2015.06.026","article-title":"Could MicroRNA polymorphisms influence warfarin dosing? A pharmacogenetics study on mir133 genes","volume":"136","author":"Ciccacci","year":"2015","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13542_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1000954","article-title":"A covering method for detecting genetic associations between rare variants and common phenotypes","volume":"6","author":"Bhatia","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"10.1111\/jth.13542_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2010-11-11-r118","article-title":"Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level","volume":"11","author":"Harismendy","year":"2010","journal-title":"Genome Biol"},{"key":"10.1111\/jth.13542_bb0130","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/gepi.21699","article-title":"Detecting rare variant effects using extreme phenotype sampling in sequencing association studies","volume":"37","author":"Barnett","year":"2013","journal-title":"Genet Epidemiol"},{"key":"10.1111\/jth.13542_bb0135","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1182\/blood-2014-04-568436","article-title":"Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans","volume":"124","author":"Daneshjou","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13542_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2011.11.043","article-title":"Influence of CYP4F2 genotype on warfarin dose requirement \u2013 a systematic review and meta\u2010analysis","volume":"130","author":"Liang","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13542_bb0145","doi-asserted-by":"crossref","first-page":"e44064","DOI":"10.1371\/journal.pone.0044064","article-title":"Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta\u2010analysis","volume":"7","author":"Jorgensen","year":"2012","journal-title":"PLoS One"},{"key":"10.1111\/jth.13542_bb0150","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00228-015-1915-y","article-title":"Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves","volume":"71","author":"Chung","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/jth.13542_bb0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cts.12385","article-title":"Impact of GGCX, STX1B and FPGS polymorphisms on warfarin dose requirements in European\u2010Americans and Egyptians","volume":"1","author":"Hamadeh","year":"2016","journal-title":"Clin Transl Sci"},{"key":"10.1111\/jth.13542_bb0160","first-page":"197","article-title":"Effects of DNMT3A gene mutations on prognosis of patients with acute myeloid leukemia: a meta\u2010analysis","volume":"44","author":"Xi","year":"2015","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1111\/jth.13542_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2014.00080","article-title":"DNA methyltransferases: a novel target for prevention and therapy","volume":"4","author":"Subramaniam","year":"2014","journal-title":"Front Oncol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13542","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622031488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622031488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13542\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:16:42Z","timestamp":1761535002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622031488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1538783622031488"],"URL":"https:\/\/doi.org\/10.1111\/jth.13542","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel variants associated with warfarin stable dosage by use of a two\u2010stage extreme phenotype strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Journal of Thrombosis and Haemostasis. Published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}